• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮来源的人卵巢癌细胞系中各种标志物物质的产生。

Production of various marker substances in human ovarian cancer cell lines of epithelial origin.

作者信息

Sekiya S, Tanaka N, Takamizawa H

机构信息

Department of Obstetrics and Gynecology, Chiba University School of Medicine, Japan.

出版信息

Arch Gynecol Obstet. 1990;248(2):103-10. doi: 10.1007/BF02389582.

DOI:10.1007/BF02389582
PMID:2078056
Abstract

Some characteristics of cell biology and the production of various tumor markers were examined using 8 human ovarian cancer cell lines of epithelial origin. Structural abnormalities of chromosomes 1, 3, and 6 were relatively common karyotypic changes among the cell lines. Cytoplasmic estradiol or progesterone receptor was not detected in any of the cell lines. A significant heterogeneity of the production of various tumor markers (ferritin, tissue peptide antigen, carcinoembryonic antigen, carbohydrate antigens 125, and 19-9) was noted among the cell lines grown in culture medium supplemented with serum. Three of the 8 cell lines were adapted to proliferate in completely synthetic serum-free culture medium. In addition to marker substances described above, small amounts of progesterone or human chorionic gonadotropin were produced in 2 of the 3 cell lines grown in serum-free culture medium. These results indicate that various marker substances including tumor markers are not produced consistently by human ovarian cancer cells of epithelial origin.

摘要

利用8种上皮来源的人卵巢癌细胞系,研究了细胞生物学的一些特征以及各种肿瘤标志物的产生情况。1号、3号和6号染色体的结构异常是这些细胞系中相对常见的核型变化。在任何一个细胞系中均未检测到细胞质雌二醇或孕酮受体。在添加血清的培养基中培养的细胞系中,各种肿瘤标志物(铁蛋白、组织多肽抗原、癌胚抗原、糖类抗原125和19-9)的产生存在显著异质性。8个细胞系中的3个适应于在完全合成的无血清培养基中增殖。除上述标志物物质外,在无血清培养基中培养的3个细胞系中的2个产生了少量孕酮或人绒毛膜促性腺激素。这些结果表明,包括肿瘤标志物在内的各种标志物物质并非由上皮来源的人卵巢癌细胞一致产生。

相似文献

1
Production of various marker substances in human ovarian cancer cell lines of epithelial origin.上皮来源的人卵巢癌细胞系中各种标志物物质的产生。
Arch Gynecol Obstet. 1990;248(2):103-10. doi: 10.1007/BF02389582.
2
Morphologic characteristics, proliferation, and tumor marker expression of two human ovarian carcinoma cell lines in three-dimensional culture.
Gynecol Oncol. 1993 Feb;48(2):155-64. doi: 10.1006/gyno.1993.1027.
3
Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Arch Gynecol Obstet. 1988;243(2):69-81. doi: 10.1007/BF00932972.
4
Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.血清和组织中的癌胚抗原、铁蛋白及组织多肽抗原。与乳腺癌中受体含量的关系。
Cancer. 1986 Mar 1;57(5):917-22. doi: 10.1002/1097-0142(19860301)57:5<917::aid-cncr2820570506>3.0.co;2-m.
5
Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.癌抗原125、组织多肽抗原、癌胚抗原及β链人绒毛膜促性腺激素作为上皮性卵巢癌的血清标志物。
Cancer. 1988 Jan 1;61(1):76-83. doi: 10.1002/1097-0142(19880101)61:1<76::aid-cncr2820610113>3.0.co;2-g.
6
[Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma].
Hum Cell. 1990 Mar;3(1):52-6.
7
Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen.
Oncology. 1990;47(2):177-84. doi: 10.1159/000226813.
8
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.卵巢癌、交界性肿瘤或良性附件肿块患者的CA-125、癌胚抗原、组织多肽抗原和胎盘碱性磷酸酶的预处理血清水平:对鉴别诊断的意义。
Gynecol Oncol. 1990 Oct;39(1):16-25. doi: 10.1016/0090-8258(90)90393-y.
9
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
Gynecol Oncol. 1990 Oct;39(1):26-33. doi: 10.1016/0090-8258(90)90394-z.
10
[Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].[人卵巢腺癌细胞系OC-8611的建立与鉴定]
Zhonghua Zhong Liu Za Zhi. 1989 Nov;11(6):416-8.

引用本文的文献

1
Interleukin-6 (IL-6) production in carcinoma of the cervix.
Arch Gynecol Obstet. 1996;258(1):25-33. doi: 10.1007/BF01370929.
2
Expression of a human multidrug resistance gene in human ovarian carcinoma cell lines.
Arch Gynecol Obstet. 1992;251(2):79-86. doi: 10.1007/BF02759915.

本文引用的文献

1
Cell heterogeneity in human ovarian carcinoma.人类卵巢癌中的细胞异质性
J Cell Physiol Suppl. 1984;3:117-22. doi: 10.1002/jcp.1041210414.
2
The cellular biology of a newly established cell line of human ovarian adenocarcinoma in vitro.
Keio J Med. 1974 Jun;23(2):53-70. doi: 10.2302/kjm.23.53.
3
Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component).两种人卵巢子宫内膜样癌细胞系(有或无鳞状细胞成分)的建立与鉴定
Gynecol Oncol. 1986 Sep;25(1):95-107. doi: 10.1016/0090-8258(86)90070-3.
4
Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma.源自人卵巢浆液性囊腺癌的新建立细胞系HUOA的特性分析
Nihon Sanka Fujinka Gakkai Zasshi. 1987 May;39(5):831-6.
5
Cytological properties of human ovarian carcinoma cell lines.人卵巢癌细胞系的细胞学特性
Asia Oceania J Obstet Gynaecol. 1987 Mar;13(1):79-86. doi: 10.1111/j.1447-0756.1987.tb00014.x.
6
Cellular heterogeneity in human epithelial neoplasms.人类上皮性肿瘤中的细胞异质性。
Int J Cell Cloning. 1988 May;6(3):161-78. doi: 10.1002/stem.5530060303.
7
[Establishment and characterization of human ovarian endometrioid carcinoma cell line].
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Feb;41(2):161-6.
8
The CA 125 tumour-associated antigen: a review of the literature.CA 125肿瘤相关抗原:文献综述
Hum Reprod. 1989 Jan;4(1):1-12. doi: 10.1093/oxfordjournals.humrep.a136832.
9
The clinical usefulness and limitations of tumor markers.肿瘤标志物的临床应用价值与局限性。
Surg Gynecol Obstet. 1988 Jun;166(6):567-79.
10
In vitro and in vivo studies of the production of placental proteins (HCG, SP1, PPs) in human choriocarcinoma cell lines.
Arch Gynecol Obstet. 1987;241(2):111-20. doi: 10.1007/BF00931231.